Publications by authors named "Elizabeth Gabitzsch"

Claim this Profile
M
Mucosal delivery of influenza antigens using a replication deficient adenovirus supports broadly reactive antibody responses and heterologous viral immunity in the respiratory tract of animals.
Michael D Schultz, Davide Botta, Aaron Silva-Sanchez, Isabella R Cheatwood, Davies Kalange, Elizabeth S Gabitzsch

bioRxiv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterologous saRNA Prime, DNA Dual-Antigen Boost SARS-CoV-2 Vaccination Elicits Robust Cellular Immunogenicity and Cross-Variant Neutralizing Antibodies.
Adrian Rice, Mohit Verma, Emily Voigt, Peter Battisti, Sam Beaver, Elizabeth Gabitzsch

Front Immunol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual-Antigen COVID-19 Vaccine Subcutaneous Prime Delivery With Oral Boosts Protects NHP Against SARS-CoV-2 Challenge.
Elizabeth Gabitzsch, Jeffrey T Safrit, Mohit Verma, Adrian Rice, Peter Sieling

Front Immunol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intranasal plus subcutaneous prime vaccination with a dual antigen COVID-19 vaccine elicits T-cell and antibody responses in mice.
Adrian Rice, Mohit Verma, Annie Shin, Lise Zakin, Peter Sieling, Elizabeth Gabitzsch

Sci Rep· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adenoviral vector-based vaccine is fully protective against lethal Lassa fever challenge in Hartley guinea pigs.
Junki Maruyama, Elizabeth J Mateer, John T Manning, Rachel Sattler, Alexey V Seregin, Elizabeth S Gabitzsch

Vaccine· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and characterization of enhancer agonist human cytotoxic T-cell epitopes of the human papillomavirus type 16 (HPV16) E6/E7.
Kwong Y Tsang, Massimo Fantini, Romaine I Fernando, Claudia Palena, Justin M David, Elizabeth S Gabitzsch

Vaccine· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The generation and analyses of a novel combination of recombinant adenovirus vaccines targeting three tumor antigens as an immunotherapeutic.
Elizabeth S Gabitzsch, Kwong Yok Tsang, Claudia Palena, Justin M David, Massimo Fantini

Oncotarget· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended evaluation of a phase 1/2 trial on dosing, safety, immunogenicity, and overall survival after immunizations with an advanced-generation Ad5 [E1-, E2b-]-CEA(6D) vaccine in late-stage colorectal cancer.
Joseph P Balint, Elizabeth S Gabitzsch, Adrian Rice, Yvette Latchman, Younong Xu

Cancer Immunol Immunother· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients.
Michael A Morse, Arvind Chaudhry, Elizabeth S Gabitzsch, Amy C Hobeika, Takuya Osada

Cancer Immunol Immunother· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Control of SIV infection and subsequent induction of pandemic H1N1 immunity in rhesus macaques using an Ad5 [E1-, E2b-] vector platform.
Elizabeth S Gabitzsch, Joseph P Balint-Junior, Younong Xu, Stephanie Balcaitis, Brigitte Sanders-Beer

Vaccine· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction and comparison of SIV immunity in Ad5 naïve and Ad5 immune non-human primates using an Ad5 [E1-, E2b-] based vaccine.
Elizabeth S Gabitzsch, Younong Xu, Joseph P Balint, Stephanie Balcaitis, Brigitte Sanders-Beer

Vaccine· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of influenza virus shedding and protection from lethal H1N1 challenge using a consensus 2009 H1N1 HA and NA adenovirus vector vaccine.
Frank R Jones, Elizabeth S Gabitzsch, Younong Xu, Joseph P Balint, Viktoriya Borisevich

Vaccine· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-tumor immunotherapy despite immunity to adenovirus using a novel adenoviral vector Ad5 [E1-, E2b-]-CEA.
Elizabeth S Gabitzsch, Younong Xu, Joseph P Balint, Zachary C Hartman, H Kim Lyerly

Cancer Immunol Immunother· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Adenovirus type 5 vaccine platform induces cellular immunity against HIV-1 Gag, Pol, Nef despite the presence of Ad5 immunity.
Elizabeth S Gabitzsch, Younong Xu, Lois H Yoshida, Joseph Balint, Andrea Amalfitano

Vaccine· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aedes triseriatus females transovarially infected with La Crosse virus mate more efficiently than uninfected mosquitoes.
Sara M Reese, Meaghan K Beaty, Elizabeth S Gabitzsch, Carol D Blair, Barry J Beaty

J Med Entomol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A preliminary and comparative evaluation of a novel Ad5 [E1-, E2b-] recombinant-based vaccine used to induce cell mediated immune responses.
Elizabeth S Gabitzsch, Younong Xu, Lois H Yoshida, Joseph Balint, Richard B Gayle

Immunol Lett· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bartonella spp. and Rickettsia felis in fleas, Democratic Republic of Congo.
Cherilyn Sackal, Anne Laudisoit, Michael Kosoy, Robert Massung, Marina E Eremeeva, Elizabeth Gabitzsch

Emerg Infect Dis· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a real-time quantitative PCR assay to enumerate Yersinia pestis in fleas.
Elizabeth S Gabitzsch, Rommelle Vera-Tudela, Rebecca J Eisen, Scott W Bearden, Kenneth L Gage

Am J Trop Med Hyg· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A doxycycline hyclate rodent bait formulation for prophylaxis and treatment of tick-transmitted Borrelia burgdorferi.
Marc C Dolan, Nordin S Zeidner, Elizabeth Gabitzsch, Gabrielle Dietrich, Jeff N Borchert

Am J Trop Med Hyg· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A sustained-release formulation of doxycycline hyclate (Atridox) prevents simultaneous infection of Anaplasma phagocytophilum and Borrelia burgdorferi transmitted by tick bite.
Nordin S Zeidner, Robert F Massung, Marc C Dolan, Eric Dadey, Elizabeth Gabitzsch

J Med Microbiol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transfer of Borrelia burgdorferi s.s. infection via blood transfusion in a murine model.
Elizabeth S Gabitzsch, Joseph Piesman, Marc C Dolan, Christine M Sykes, Nordin S Zeidner

J Parasitol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylactic use of sustained-release doxycycline blocks tick-transmitted infection by Anaplasma phagocytophilum in a murine model.
Robert F Massung, Nordin S Zeidner, Marc C Dolan, Dawn Roellig, Elizabeth Gabitzsch

Ann N Y Acad Sci· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis